Healthcare provider profile · identity verified

Benjamin Edward Ball, D.O.

Internal Medicine · BELLEVUE, OH · NPI 1083637730

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	691	163
Atorvastatin Calcium	Atorvastatin Calcium	687	171
Lisinopril	Lisinopril	401	90
Losartan Potassium	Losartan Potassium	394	94
Levothyroxine Sodium	Levothyroxine Sodium	349	61
Omeprazole	Omeprazole	257	67
Metoprolol Succinate	Metoprolol Succinate	254	63
Carvedilol	Carvedilol	237	51
Metformin Hcl	Metformin Hcl	203	49
Tramadol Hcl	Tramadol Hcl	181	30
Escitalopram Oxalate	Escitalopram Oxalate	174	40
Furosemide	Furosemide	169	48
Tamsulosin Hcl	Tamsulosin Hcl	161	44
Benazepril Hcl	Benazepril Hcl	155	40
Pantoprazole Sodium	Pantoprazole Sodium	154	47
Eliquis	Apixaban	151	27
Allopurinol	Allopurinol	149	31
Alprazolam	Alprazolam	149	27
Hydrochlorothiazide	Hydrochlorothiazide	149	41
Clopidogrel	Clopidogrel Bisulfate	148	37
Glimepiride	Glimepiride	148	26
Gabapentin	Gabapentin	144	34
Famotidine	Famotidine	139	32
Prednisone	Prednisone	129	60
Metoprolol Tartrate	Metoprolol Tartrate	114	29
Warfarin Sodium	Warfarin Sodium	114	24
Pravastatin Sodium	Pravastatin Sodium	108	27
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	106	20
Potassium Chloride	Potassium Chloride	106	27
Albuterol Sulfate Hfa	Albuterol Sulfate	104	35
Trazodone Hcl	Trazodone Hcl	100	17
Buspirone Hcl	Buspirone Hcl	97	18
Doxycycline Hyclate	Doxycycline Hyclate	94	68
Rosuvastatin Calcium	Rosuvastatin Calcium	94	25
Ozempic	Semaglutide	87	17
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	84	23
Sertraline Hcl	Sertraline Hcl	81	21
Azithromycin	Azithromycin	73	50
Torsemide	Torsemide	73	16
Ropinirole Hcl	Ropinirole Hcl	69	suppressed
Meloxicam	Meloxicam	68	20
Citalopram Hbr	Citalopram Hydrobromide	65	15
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	63	17
Isosorbide Mononitrate Er	Isosorbide Mononitrate	63	15
Zolpidem Tartrate	Zolpidem Tartrate	60	14
Atenolol	Atenolol	59	17
Tizanidine Hcl	Tizanidine Hcl	59	16
Spironolactone	Spironolactone	57	suppressed
Clonazepam	Clonazepam	56	11
Xarelto	Rivaroxaban	55	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	54	13
Jardiance	Empagliflozin	53	suppressed
Trulicity	Dulaglutide	51	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	49	11
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	45	13
Nabumetone	Nabumetone	44	12
Triamcinolone Acetonide	Triamcinolone Acetonide	43	30
Celecoxib	Celecoxib	42	suppressed
Mirtazapine	Mirtazapine	42	suppressed
Temazepam	Temazepam	42	suppressed
Valsartan	Valsartan	42	suppressed
Klor-Con M20	Potassium Chloride	41	suppressed
Hydralazine Hcl	Hydralazine Hcl	40	suppressed
Diclofenac Sodium	Diclofenac Sodium	39	suppressed
Montelukast Sodium	Montelukast Sodium	39	suppressed
Simvastatin	Simvastatin	39	11
Fluticasone Propionate	Fluticasone Propionate	37	15
Insulin Lispro Kwikpen U-100	Insulin Lispro	36	suppressed
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	35	suppressed
Mupirocin	Mupirocin	35	25
Tradjenta	Linagliptin	35	suppressed
Alendronate Sodium	Alendronate Sodium	33	suppressed
Labetalol Hcl	Labetalol Hcl	33	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	33	suppressed
Baclofen	Baclofen	32	14
Duloxetine Hcl	Duloxetine Hcl	32	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	32	23
Bupropion Xl	Bupropion Hcl	31	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	31	suppressed
Telmisartan	Telmisartan	30	12
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	29	21
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	29	suppressed
Lovastatin	Lovastatin	29	suppressed
Nystatin	Nystatin	29	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	28	12
Hydroxyzine Hcl	Hydroxyzine Hcl	26	suppressed
Lorazepam	Lorazepam	26	13
Ondansetron Odt	Ondansetron	25	13
Donepezil Hcl	Donepezil Hcl	24	suppressed
Ezetimibe	Ezetimibe	24	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	24	suppressed
Amoxicillin	Amoxicillin	23	17
Finasteride	Finasteride	23	suppressed
Memantine Hcl	Memantine Hcl	22	suppressed
Synthroid	Levothyroxine Sodium	22	suppressed
Fenofibrate	Fenofibrate	21	suppressed
Levofloxacin	Levofloxacin	21	19
Verapamil Er	Verapamil Hcl	21	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	20	suppressed
Fluconazole	Fluconazole	20	12
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	20	suppressed
Diazepam	Diazepam	19	suppressed
Entresto	Sacubitril/Valsartan	19	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	19	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	18	suppressed
Glipizide	Glipizide	18	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	18	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	18	18
Pregabalin	Pregabalin	18	suppressed
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	17	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	17	suppressed
Novolog Flexpen	Insulin Aspart	17	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	17	suppressed
Breo Ellipta	Fluticasone/Vilanterol	16	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	16	12
Clonidine	Clonidine	16	suppressed
Clonidine Hcl	Clonidine Hcl	16	suppressed
Farxiga	Dapagliflozin Propanediol	16	suppressed
Latanoprost	Latanoprost	16	suppressed
Linzess	Linaclotide	16	suppressed
Novolin 70-30 Flexpen	Insulin Nph Hum/Reg Insulin Hm	16	suppressed
Valacyclovir	Valacyclovir Hcl	16	suppressed
Bumetanide	Bumetanide	15	suppressed
Cefuroxime	Cefuroxime Axetil	15	12
Etodolac	Etodolac	15	suppressed
Sildenafil Citrate	Sildenafil Citrate	15	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	14	suppressed
Humalog Kwikpen U-100	Insulin Lispro	14	suppressed
Hydrocortisone	Hydrocortisone	14	suppressed
Oxcarbazepine	Oxcarbazepine	14	suppressed
Amiodarone Hcl	Amiodarone Hcl	13	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	13	suppressed
Clorazepate Dipotassium	Clorazepate Dipotassium	13	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	13	suppressed
Estradiol	Estradiol	13	suppressed
Ipratropium Bromide	Ipratropium Bromide	13	suppressed
Ramipril	Ramipril	13	suppressed
Toprol Xl	Metoprolol Succinate	13	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	12	suppressed
Buprenorphine	Buprenorphine	12	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	12	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	12	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	12	suppressed
Minocycline Hcl	Minocycline Hcl	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Valproic Acid	Valproic Acid	12	suppressed
Butalb-Acetaminoph-Caff-Codein	Butalbit/Acetamin/Caff/Codeine	11	suppressed
Cephalexin	Cephalexin	11	suppressed
Colestipol Hcl	Colestipol Hcl	11	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	11	suppressed
Glipizide Er	Glipizide	11	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	11	suppressed
Januvia	Sitagliptin Phosphate	11	suppressed
Lactulose	Lactulose	11	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed
Novolin N	Insulin Nph Human Isophane	11	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	11	suppressed
Oxycodone Hcl	Oxycodone Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error